Ixico names Bram Goorden as next chief executive officer

(Alliance News) - Ixico PLC on Monday said Bram Goorden will succeed the company's outgoing head, ...

Alliance News 5 August, 2024 | 1:30PM
Email Form Facebook Twitter LinkedIn RSS

(Alliance News) - Ixico PLC on Monday said Bram Goorden will succeed the company's outgoing head, bringing with him two decades of industry-specific knowledge.

The London-based precision analytics and medical imaging services provider announced that Bram Goorden will join the company as chief executive officer on August 19, replacing retiring Giulio Cerroni.

Chair Mark Warne said: "I am delighted to welcome Bram to the board as our CEO. Bram has significant track record in the commercial application of AI precision medicine solutions that is complemented by technical knowledge within neurodegenerative diseases. As IXICO looks to return to growth, Bram's experiences provide excellent credentials to ensure IXICO also realises shareholder value."

Goorden has more than two decades of experience working in biopharma and precision medicines, having served in senior management roles at Eli Lilly & Co and UCB Pharma SA.

More recently, Goorden was chief operating officer at Eagle Genomics Ltd where he expanded the company's US footprint and delivered key industry alliances.

Ixico shares were up 7.1% to 7.50 pence each in London on Monday afternoon.

By Elijah Dale, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
IXICO PLC 6.75 GBX -3.57 -
Eli Lilly and Co 765.60 USD -4.83

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures